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Abstract
Cognitive enhancement is the use of any (legitimate) means to reach one’s personal best cognitive performance. Cognitive
enhancement can help delay cognitive decline in the elderly. Along the same lines, training children could speed up the education
and reduce the risk of behavioral deviance and pathology. Nonetheless, cognitive enhancement is one of the most widely
discussed topics in neuroethics because it is considered by some authors to be Bunnatural^ and to create Bpositional benefits.^
In this opinion article, I will present examples of cognitive enhancement from the field of food supplements, pharmacology, and
brain stimulation. I propose the idea of a responsible cognitive enhancement supported by clear mechanisms of action, that takes
into account individual differences and that evaluates the far-reaching, sweeping claims from the media and the industry.
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Introduction
Cognitive enhancement is the use of any (legitimate)means (e.g.,
meditation, smart drugs, brain stimulation, neurofeedback, phys-
ical exercise, or food supplements) to reach one’s personal best.
Cognitive enhancement can help compensate for cognitive de-
cline in the elderly, whichwould prolong the time people can live
autonomously and, thus, reduce the welfare costs for the time
thereafter. Along the same lines, training children could
Baccelerate^ the education of healthy individuals and minimize
the risk of behavioral deviance and pathology, again with con-
siderable savings for welfare and education systems.
Notwithstanding these potential benefits, cognitive en-
hancement is one of the most extensively discussed issues in
neuroethics (Bostrom and Sandberg 2009). There are at least
two ethical aspects to take into consideration. The first regards
the Bfairness^ of the intervention. It has been suggested that
techniques of cognitive enhancement may disregard human
nature and dignity and encourage cheating behavior and an
unrestrained tendency to perfectionism (Habermas 2003; Kass
2002). These worries are real given the growing use of
cognitive-enhancing drugs, such as Modafinil (Colzato and
Mourits 2017) and Ritalin (Colzato and Arntz 2017), by stu-
dents to enhance their academic skills and output. It is not to
exclude that in the future universities might consider banning
the use of those drugs or to allow them only under certain
circumstances (exams). The same applies not only to drugs
but to commercially brain stimulation devices, which can be
bought online without any restrictions (Steenbergen et al.
2016).
The second ethical aspect emerges from the discrepancy be-
tween two widely shared ethical principles underlying Western
society: individual freedom and equality. Even though effective
cognitive-enhancing programs can be regarded as a manifesta-
tion of individual freedom, theymay collide with equality. Given
that contemporary globalized societies are based on competition,
which underlines individual skills and performance, cognitive
enhancement might cause Bpositional benefits^ by ameliorating
one’s social and economic status as compared to others.
Despite the fact that this could be regarded as a fair indi-
vidual choice, it may have repercussions for general public
expectations and standards. Indeed, a general public pressure
to improve one’s cognitive abilities could arise once a number
of individuals have shown that this is possible. That is, the
simple option to enhance one’s cognitive abilities could in-
crease social competition by boosting the pressure of always
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Bbeing on top^ and to work harder, longer, and more inten-
sively, which in the end may exacerbate the problems one was
initially aiming to solve. Further, as the probability to profit
from cognitive-enhancing interventions may differ between
individuals, the availability of enhancing programs may con-
tribute to the emergence, and increase the size of, societal gaps
(Bostrom and Sandberg 2009). Nevertheless, cognitive-
enhancing interventions could be used as a way of decreasing,
rather than increasing societal/social inequalities by allowing
all, and not just the economically privileged individuals, to
fully achieve their cognitive potential. This would not elimi-
nate competition but create more equal terms (Savulescu
2009). Indeed, it is important to consider that the extensive
use of cognitive-enhancing methods and the accompanying
cognitive benefits might have important social benefits.
Some studies estimate that boosting the average IQ of the
world population by no more than 3% would reduce poverty
rates by 25% (Schwartz 1994) and result in an annual eco-
nomic gain of US $165–195 billion and 1.2–1.5% of the na-
tional gross domestic product (Salkever 1995).
Responsible Cognitive Enhancement
Kurt Lewin’s claim that Bnothing is as practical as a good theory^
is the leitmotif of this opinion paper about cognitive enhance-
ment. Whereas in the past the field of cognitive enhancement
used mainly effect-driven approaches (that seek to demonstrate
that an enhancing intervention can have an effect without
explaining how it modulates the targeted function and why some
people benefit more than others), this paper suggests a mecha-
nistically oriented, theory-driven approach that tries to under-
stand and explain individual differences to a degree that allows
a comprehensive understanding of how a particular intervention
modulates cognition. I argue that only a theory-driven enhance-
ment is a responsible cognitive enhancement, because only if we
understand the mechanism of actions can we make effective
prediction about the direction of the intended intervention.
The present paper presents three different means to en-
hance cognition and is divided into three parts. The first is
devoted to tyrosine (TYR), a neurotransmitter precursor that
enhances cognition in young adults but impairs it in the elder-
ly. The second and third parts take as examples Bmicrodosing^
psychedelics and commercial brain stimulation devices to un-
derlie the necessity for an active role of scientists in evaluating
the far-reaching, sweeping claims from the media and/or in-
dustry to achieve a responsible cognitive enhancement.
Tyrosine: Paradox Effects Across the Life Span
TYR is one of themost investigated amino acid. It is contained in
many kinds of food, such as codfish, almonds, and milk. From a
theoretical point of view, TYR is very interesting because it is the
chemical forerunner of the neurotransmitter dopamine (Colzato
2017). TYR administration can augment dopamine levels in the
brain (Cuche et al. 1985; Gibson and Wurtman 1977; Tam et al.
1990). Once it has passed the blood-brain barrier and is taken up
by the appropriate brain cells, the enzyme tyrosine-hydroxylase
(Daubner et al. 2011) converts TYR into L-DOPA and then into
dopamine. In young adults, when the enzyme tyrosine-
hydroxylase works properly, TYR administration has been found
to be beneficial for dopaminergic-related functions such as work-
ing memory performance (Colzato et al. 2013). In a recent study,
we took into account individual differences (i.e., genetic differ-
ences) in dopamine baseline levels to explain the effectivity of
TYR. Indeed, the study showed evidence supporting the idea that
TYR supplementation may function as a cognitive enhancer and
compensate for unfavorable genetic predisposition (Colzato et al.
2016). In a new study, we wanted to examine the possibility that
TYR, aimed at increasing dopamine levels, is likely to slow
down, and (partially) compensate for the cognitive decline asso-
ciated with the aging-related loss of dopaminergic supplies. In
contrast to our expectations, our findings show detrimental ef-
fects of TYR on working memory suggesting that, in contrast to
young adults (Colzato et al. 2013, 2014; Steenbergen et al. 2015),
the administration of TYR in aging may be counterproductive.
How is it possible for TYR to be beneficial in young adults,
but detrimental in old adults? TYR administration may be detri-
mental for performance when the dopamine system is impaired
by a number of different factors, such as in aging. One of these
factors is latent Toxoplasma gondii (T. gondii). This infection is
known to impair the function of tyrosine hydroxylase and lead to
abnormal conversion rates of TYR.Given the high incidence and
prevalence of seropositivity of this infection (up to 77%) in aging
(Wilking et al. 2016), TYR administration may have decreased
performance in old adults because of their potential seropositivity
of T. gondii. That is, it is possible that in seropositive individuals,
the abnormal conversion rates of TYR drove our participants
beyond optimality (i.e., in the inverted-U-shape function that
catecholinergic functions follow) and impaired their working
memory performance.
The example of TYR is important because it underlies the
fact that only via understanding the mechanism of actions are
we able to predict the direction of an intervention and to ex-
plain why in some cases an intervention is enhancing and in
other cases is impairing cognitive functions.
Hype in the Media: Microdosing Psychedelics
Major newspaper articles worldwide are reporting on the ris-
ing number of professionals using small doses of psychedelics
(e.g., magic mushrooms, truffles, or peyote) to enhance their
productivity and creativity at work. A notable example is the
use of small doses of LSD by employees in Silicon Valley, as a
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Bproductivity hack^ (Glatter 2015). This emerging phenome-
non is referred to as microdosing, with dosages around one
tenth of recreational doses.
Even though in the media microdosing psychedelics is al-
ready portrayed as a valid cognitive enhancer, no studies have
investigated the quantitative effects of it. Indeed, so far, the
only evidence is based on qualitative studies which are based
on self-reports and are known to suffer from validity problems
due to participants’ inaccurate memories, differences in vo-
cabulary and verbal skills, and unintentional or willful distor-
tions of subjective experiences (Schwarz 1999).
Classical psychedelics such as psilocybin are known to aug-
ment the serotonergic system (Tylš et al. 2014) and to enhance
mental flexibility (Boulougouris and Robbins 2010), the main
ingredient of creativity. Creativity is commonly defined as the
ability to generate ideas, solutions, or products that are both
novel and appropriate (e.g., Amabile 1996; Sternberg and
Lubart 1999). Given that (a) microdosing psychedelics is pre-
sented in the media as Ba matter of fact^ substance to boost
creativity and (b) the theoretical link between cognitive flexi-
bility and serotonin, we quantitatively investigated the effects of
microdosing truffles during microdosing events of the
Psychedelic Society of The Netherlands. We examined the ef-
fects of psychedelic truffles on two creativity-related problem-
solving tasks: the Picture Concept Task assessing convergent
thinking, and the Alternative Uses Task assessing divergent
thinking. A short version of the Raven’s Progressive Matrices
task was administered to measure potential changes in fluid
intelligence. We tested the participants twice: once before tak-
ing a microdose (pre-test) and once 90 min after the ingestion
(post-test). Both convergent and divergent thinking perfor-
mance were enhanced after a non-blinded microdose, while
fluid intelligence was unaffected (Prochazkova et al. 2018).
Even though this study provides quantitative support for the
cognitive-enhancing properties of microdosing psychedelics,
future research has to confirm these preliminary findings in
more rigorous placebo-controlled study designs.
The example of microdosing psychedelics makes it clear
how important it is for a responsible cognitive enhancement to
scientifically test claims made by the media.
Commercial Brain Stimulation Devices
A recent initiative supported by several eminent research insti-
tutes and scientists pleaded for a more critical and active role of
the scientific community in evaluating the sometimes far-
reaching, sweeping claims from the brain training industry with
regard to the impact of their products on cognitive performance
(Max Planck Institute on Human Development, Stanford Center
on Longevity 2014). Following this eminent recommendation,
we examined whether and to what degree the commercial trans-
cranial direct current stimulation (tDCS) headset foc.us improve
cognitive performance, as advertised in the media (Steenbergen
et al. 2016).
We showed that prefrontal cortex stimulation delivered
using the commercial foc.us tDCS headset (v.1) does not en-
hance but impairs the ability to monitor and update informa-
tion in working memory (Steenbergen et al. 2016). Even if the
consequences of long-term or frequent use of the foc.us device
are yet to be demonstrated, our results provide strong support
for a responsible cognitive enhancement which calls for the
scientific community to play a more critical and active role in
validating and testing far-reaching claims made by the brain
training industry.
Conclusion: Moving Toward a Responsible
Cognitive Enhancement
Most cognitive-enhancing programs have a one-size-fits-all de-
sign and presuppose that people benefit from the intervention
more or less the same way and to more or less the same degree.
However, in this paper, I showed evidence suggesting this is not
always plausible. I propose that the efficiency of cognitive-
enhancing interventions will often be modulated by life span
and inter-individual differences, including pre-existing
neurodevelopmental factors and differences with a genetic ba-
sis. Accordingly, only enhancing programs that are tailored to
individual abilities, skills, and needs are likely to succeed. Only
a theory-driven cognitive enhancement is a responsible cogni-
tive enhancement. Only a mechanistically oriented, theory-
driven approach will allow for the design of individualized
cognitive enhancement interventions required to make such
interventions successful for the recipient at an individual level,
and to make welfare more affordable at a societal level. Further,
to achieve a responsible cognitive enhancement, I plead the
scientific community to play a more critical and active role in
validating and testing far-reaching claims made by the media
and/or industry.
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